Greenlight Capital’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.11M | Hold |
149,052
| – | – | 0.05% | 36 |
|
|
2023
Q3 | $860K | Hold |
149,052
| – | – | 0.05% | 34 |
|
|
2023
Q2 | $1.07M | Hold |
149,052
| – | – | 0.05% | 35 |
|
|
2023
Q1 | $1.1M | Hold |
149,052
| – | – | 0.06% | 34 |
|
|
2022
Q4 | $996K | Hold |
149,052
| – | – | 0.07% | 32 |
|
|
2022
Q3 | $1.52M | Hold |
149,052
| – | – | 0.11% | 32 |
|
|
2022
Q2 | $1.82M | Hold |
149,052
| – | – | 0.14% | 37 |
|
|
2022
Q1 | $3.15M | Buy |
149,052
+44,432
| +42% | +$940K | 0.2% | 36 |
|
|
2021
Q4 | $6.29M | Buy |
+104,620
| New | +$6.29M | 0.36% | 31 |
|